
Opaldia is the UK's premier private provider of genetic medicine and lifetime wellness programmes.
We provide our customers with the highest standards of clinical care in genetic health services. We provide impartial, specialist-led information on latest testing and screening technologies and education on prevention, early detection and accurate diagnosis.
- News : OPALDIA TO LAUNCH BREAST CANCER BLOOD TEST IN 2008
- News : OPALDIA TO LAUNCH BREAST CANCER BLOOD TEST IN 2008 - News
- News : Breast Care Awareness Month Sees First Personalised Programm...
- News : Opaldia Hosts First in a Series of Genetics in General Pract...
- News : Opaldia response to new breast cancer genes discovery
- News : A new test (MammaPrint®) predicts whether breast cancer will...
- News : UK/Ireland distributor welcomes FDA clearance of breast canc...
- News : Agendia’s MammaPrint® breast cancer prognosis test cleared b...
- News : UK/Ireland distributor welcomes FDA clearance of breast canc...
- News : Opaldia agree an exclusive license with Agendia
- News : Opaldia links up with the Nuffield Hospitals to offer geneti...
Opaldia's PALS
Public Awareness Lunchtime Seminar
Thursday 26th June 2008
Opaldia's Services include:
-
comprehensive individual screening programmes for inherited disorders particularly cancer
-
genetic information services;
-
the latest proven molecular diagnostic testing for cancer;
-
R&D and clinical trials co-ordination to help advance this exciting field of medicine.
As well as providing some of the most sophisticated testing available, we deliver a level of personal care and attention to make patients feel comfortable and as free from anxiety as is possible for what is often a worrying time for both patients and their families.

